Publications by authors named "Abel Tezera Abebe"

Guillain-Barré syndrome (GBS) is an acute autoimmune polyneuropathy with substantial geographic variations in demography, antecedent events, clinical manifestations, electrophysiological sub-types, diagnostic findings, treatment modalities, and prognostic indicators. However, there is limited contemporary data on GBS patient profiles and prognostic factors from low-resource settings like Ethiopia. The objective of this study is to investigate the clinical profile, factors associated with mortality, and hospital outcomes among GBS patients admitted to Tikur Anbessa Specialized Hospital (TASH) in Addis Ababa, Ethiopia.

View Article and Find Full Text PDF
Article Synopsis
  • Over 1 billion people globally have hypertension, and a hypertensive crisis is defined as blood pressure exceeding 180/110 mmHg, potentially affecting target organ health.
  • A study at Adama Hospital Medical College in Ethiopia, conducted between January and August 2021, identified 444 cases of hypertensive crises among 9,082 EOPD patients, which is a prevalence of 4.9%.
  • The study revealed that the majority of affected patients were men aged 66-75, most were previously diagnosed with hypertension, and issues like medication non-adherence, family history, and lifestyle habits significantly contributed to the risk factors observed.
View Article and Find Full Text PDF

Background: Acute kidney injury (AKI) is a serious complication of the Corona Virus Disease of 2019 (COVID-19). However, data on its magnitude and risk factors among hospitalized patients in Ethiopia is limited. This study aimed to determine the magnitude of AKI and associated factors among patients admitted for severe COVID-19 pneumonia.

View Article and Find Full Text PDF

The third edition of the International Classification of Headache Disorders (ICHD-3) defines medication-overuse headache (MOH) as a headache that develops when a person regularly uses acute or symptomatic headache medications excessively (10 or more, or 15 or more days per month, depending on the medication) for a period of time longer than 3 months. Even though it may not be reported as frequently as it actually is, it affects about 5% of the general population on average. It typically happens following repeated anti-pain medication use for pre-existing headache disorders, such as migraines.

View Article and Find Full Text PDF